Quality of life in patients with lung cancer: the way forward
Menée dans 12 pays à partir de données portant sur 523 patients atteints d’un cancer du poumon (442 cas de cancer du poumon non à petites cellules et 81 cas de cancer du poumon à petites cellules), cette étude analyse l’efficacité d’un nouveau module du questionnaire EORTC permettant d’évaluer leur qualité de vie
Despite important treatment progress, lung cancer, which is often diagnosed as advanced disease, is still characterised by a poor prognosis. Quality-of-life (QOL) evaluation, defined as the patients' perception of the physical, psychological, and social impact of cancer and its treatment, has a central role, together with the classic endpoints of efficacy and safety, in understanding the real value of a treatment and its potential risks and benefits.
The Lancet Oncology , commentaire, 2019